Home
Laurus Labs Ltd Share Price History
Laurus Labs Ltd
NSE : 04 Apr, 2025
574.45-46.2 (-7.4%)
Prev Close
620.7
Open Price
620.7
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
3744040
Today's High / Low
621.8 / 561.5
52 WK High / Low
646.2 / 385.5
Market Price of Laurus Labs Ltd
1M
1Y
3Y
5Y
Monitoring Laurus Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 17.99 |
| YoY Gr. | - |
| Net Profit (Cr.) | 190 |
| BVPS | 125.8 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 13.83 |
| Op. Profit Mgn % | 17.51 |
| Net Profit Mgn % | 5.09 |
| Debt to Equity % | 1.26 |
Latest Shareholding
Promoters Holdings Over Time
About Laurus Labs Ltd
- Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.
- The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others.
- The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh.
- Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The company's strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing 'donor-funded access-to-medicines markets' of Sub-Saharan Africa, South-East Asia and Latin America.
Popular Search
FAQs for Laurus Labs Ltd Share Price History
What are the key events that typically impact Laurus Labs Ltd's share price history?
Key events that impact Laurus Labs Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Laurus Labs Ltd's share price history?
Stock splits reduce the nominal price of Laurus Labs Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Laurus Labs Ltd?
Dividends can influence Laurus Labs Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Laurus Labs Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Laurus Labs Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Laurus Labs Ltd’s share price history?
To understand Laurus Labs Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
